Key Takeaways
- • Irish tech SMEs raised €113.8m in venture funding in Q3 2026, down from €207.9m a year earlier, a decline of roughly 45pc and the lowest third-quarter level in 10 years, according to the IVCA's VenturePulse Q3 2026 survey.
- • International VC funding plummeted 76pc to €35.5m in Q3 from €146.7m, prompting IVCA chair Richard Watson to warn of overdependence on international investors.
- • Year-to-date funding from January to September 2026 fell about 19pc to €692.2m from €853.4m, while deal count dipped marginally from 136 to 129.
- • Companies raising €1m-€5m faced a pronounced squeeze: deals in that bracket fell from 30 to 12 in Q3, and €3m-€5m rounds fell 56pc year-to-date to €37.2m.
- • Software led Q3 by sector and accounted for the three largest deals, including a €13m minority investment in Limerick-based Redfaire; life sciences (24pc) and fintech (22pc) hold the largest year-to-date shares.
Summary
Irish technology SMEs recorded their lowest third-quarter venture capital funding in ten years in Q3 2026, according to the VenturePulse Q3 2026 survey published on 15 November 2026 by the Irish Venture Capital & Private Equity Association (IVCA) and William Fry. Equity funding raised by Irish and Ireland-headquartered SMEs totalled €113.8m for the three months to September, down year-on-year from €207.9m, a fall of around 45pc. The survey excludes debt, venture debt, grants and other non-equity funding.
Funding from international venture capital investors was a major driver of the decline. According to the survey, international VC funding fell 76pc to €35.5m from €146.7m in the same quarter last year. IVCA chair Richard Watson said the association had been warning for some time about Ireland's overdependence on international investors.
The squeeze was most acute for companies seeking €1m-€5m. Deals in that range fell from 30 to 12 year-on-year. Rounds of €1m-€3m declined 70pc to €10.7m, while €3m-€5m rounds fell 55pc to €15.7m. Watson said the core issue is less about overall activity than whether companies can progress from pre-seed and seed into larger scale-up rounds. Sarah-Jane Larkin, director general of the IVCA, said the strain was also visible in the nine-month data, where €3m-€5m funding fell 56pc to €37.2m and €1m-€3m deals dropped 36pc to €48.7m. Combined rounds across both categories fell from 65 to 40.
Year-to-date funding from January to September 2026 totalled €692.2m, down about 19pc from €853.4m, with deal numbers falling only slightly from 136 to 129. Software was the best-represented sector in Q3 and included the three largest deals, among them a €13m minority investment in Limerick-based Redfaire. Life sciences (24pc) and fintech (22pc) have taken the largest shares of funding so far in 2026.
Watson said Ireland had been "somewhat shielded" from recent turbulence in the AI sector because it does not host large domestic frontier platform companies investing billions in infrastructure such as data centres. He argued that AI adoption is nonetheless strong across Irish healthcare, financial services, manufacturing and construction, and that these businesses will need normal venture-scale funding rather than the extraordinary sums committed by global model developers.
Funding from international venture capital investors was a major driver of the decline. According to the survey, international VC funding fell 76pc to €35.5m from €146.7m in the same quarter last year. IVCA chair Richard Watson said the association had been warning for some time about Ireland's overdependence on international investors.
The squeeze was most acute for companies seeking €1m-€5m. Deals in that range fell from 30 to 12 year-on-year. Rounds of €1m-€3m declined 70pc to €10.7m, while €3m-€5m rounds fell 55pc to €15.7m. Watson said the core issue is less about overall activity than whether companies can progress from pre-seed and seed into larger scale-up rounds. Sarah-Jane Larkin, director general of the IVCA, said the strain was also visible in the nine-month data, where €3m-€5m funding fell 56pc to €37.2m and €1m-€3m deals dropped 36pc to €48.7m. Combined rounds across both categories fell from 65 to 40.
Year-to-date funding from January to September 2026 totalled €692.2m, down about 19pc from €853.4m, with deal numbers falling only slightly from 136 to 129. Software was the best-represented sector in Q3 and included the three largest deals, among them a €13m minority investment in Limerick-based Redfaire. Life sciences (24pc) and fintech (22pc) have taken the largest shares of funding so far in 2026.
Watson said Ireland had been "somewhat shielded" from recent turbulence in the AI sector because it does not host large domestic frontier platform companies investing billions in infrastructure such as data centres. He argued that AI adoption is nonetheless strong across Irish healthcare, financial services, manufacturing and construction, and that these businesses will need normal venture-scale funding rather than the extraordinary sums committed by global model developers.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.